跳到正文
原文
Regulatory Affairs Professionals Society· @RAPSorg · X·· 13 天前精选AI 评分48
AI 导读

针对 FDA 关于生成式 AI(genAI)医疗器械的讨论文件,已提交超过 500 条意见,利益相关方就如何监管这类技术向该机构提出了多种建议。相关意见链接见 https://hubs.la/Q04DfhV70。

推荐理由

FDA 生成式 AI 医疗器械讨论文件收到逾 500 条意见,反映业界对这类技术监管路径的关注焦点。

正文

More than 500 comments have been submitted in response to the FDA discussion paper on generative AI (genAI)-enabled medical devices, and stakeholders have offered the agency a wide variety of advice on the best way to regulate these technologies.
https://hubs.la/Q04DfhV70

来源:Regulatory Affairs Professionals Society · x.com